A comparison of the effects of psychotomimetics and anxiolytics on punished and unpunished responding maintained by fixed interval schedules of food reinforcement in the rat

Behavioural Pharmacology

Volumn 17, Issue 1, 2006, Pages 87-99

  Evenden, John ^a   Duncan, Bertina ^a   Ko, Tracey ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

aminobutyric acid type A receptor; Anxiety; Chlordiazepoxide; D amphetamine; Punished responding; Rat; Unpunished responding

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; AMPHETAMINE; ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; CITALOPRAM; DEXAMPHETAMINE; DIZOCILPINE; NS 2710; PREGABALIN; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG; YOHIMBINE;

ANXIETY; ARTICLE; CORRELATION ANALYSIS; DRUG EFFECT; FOOD INTAKE; NONHUMAN; RAT; STIMULUS; TIME SERIES ANALYSIS;

AMPHETAMINES; ANIMALS; ANTI-ANXIETY AGENTS; APPETITIVE BEHAVIOR; ASSOCIATION LEARNING; BENZIMIDAZOLES; CHLORDIAZEPOXIDE; CONDITIONING, OPERANT; DEXTROAMPHETAMINE; DIZOCILPINE MALEATE; ELECTROSHOCK; GAMMA-AMINOBUTYRIC ACID; HALLUCINOGENS; OXIMES; PUNISHMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; REINFORCEMENT SCHEDULE; YOHIMBINE;

EID: 30444445696     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000189812.77049.e5     Document Type: Article

References (32)

1. Baldwin HA, Johnston AL, File SE (1989). Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol 159:211-215.
2. Benvenga MJ, Leander JD (2000). Anxiolytic-like effect of R-fluoxetine in pigeons. Soc Neurosci Abs 26:871.8.
3. Bjerkenstedt L, Edman G, Flyckt L, Hagenfeldt L, Sedvall G, Wiesel FA (1985). Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor: a dose-response study in depressed patients. Psychopharmacology 87:253-259.
4. Charney DS, Woods SW, Goodman WK, Heninger GR (1987). Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144:1030-1036.
5. Curran HV (1986). Tranquilising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 23:179-213.
6. Davis M, Redmond DE Jr, Baraban JM (1979). Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology 65:111-118.
7. Engleman EA, Murphy JM, Zhou FC, Hingtgen JN (1992). Response suppression induced with selective 5-HT agonists can be differentially blocked with LY53857 in an animal model of depression. Neurochem Res 17:483-488.
8. Evenden JL (1991). Effects of chlordiazepoxide, morphine and amphetamine on responding suppressed by different levels of electric shock in the pigeon are rate dependent. Psychopharmacology 105:253-258.
9. Feltner DE, Crockatt JG, Dubovsky SJ, Cohn CK, Shrivastava RK, Targum SD, et al. (2003). A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23:240-249.
10. Felton TM, Kang TB, Hjorth S, Auerbach SB (2003). Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. N-S Arch Pharmacol 367:297-305.
11. Field MJ, Oles RJ, Singh L (2001). Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity. Brit J Pharmacol 132:1-4.
12. Foree DD, Moretz FH, McMillan DE (1973). Drugs and punished responding II: D-amphetamine-induced increases in punished responding. J Exp Anal Behav 20:291-300.
13. Geller I, Kulak JT, Seifter J (1962). The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination. Psychopharmacologia (Berlin) 25:112-116.
14. Genovese RF, Lu XC (1991). Effects of MK-801 stereoisomers on schedule-controlled behavior in rats. Psychopharmacology 105:477-480.
15. Gurguis GN, Vitton BJ, Uhde TW (1997). Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatr Res 71:27-39.
16. Hill RT (1970). Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In: Costa ER, Garatini S, editors. Amphetamines and related compounds. Proceedings of the Mario Negri Institute for Pharmacological Research, Milan, Italy. New York: Raven Press. pp. 781-795.
17. Imanishi T, Yokoyama F, Yamauchi M, Ichimaru Y, Fujiwara M, Baba J, et al. (1999). Pharmacological profile of a novel non-benzodiazepine anxiolytic ME3127 (NS2710). Soc Neurosci Abs 25:1319.
18. Jensen ML, Timmerman DB, Varming T, Johansen TH, Ahring PK (2001). Two distinct actions of the novel anxiolytic compound NS2710 on GABAA receptors. Soc Neurosci Abs 27:1287.
19. Killcross AS, Everitt BJ, Robbins TW (1997). Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam. Psychopharmacology 129: 141-152.
20. King DJ (1992). Benzodiazepine, amnesia and sedation, theoretical and clinical issues and controversies. Hum Psychopharmacol 7:79-87.
21. Lerner T, Feldon J, Myslobodsky MS (1986). Amphetamine potentiation of anti-conflict action of chlordiazepoxide. Pharmacol Biochem Behav 24:241.
22. Maciag CM, Smolka J, Duncan B, Hudzik T, Widzowski D (2003). In search of the next generation of anxiolytics: how do they compare in efficacy vs cognitive side effects. Soc Neuroscience Abs 33:426.7.
23. Mattila M, Seppala T, Mattila MJ (1988). Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. Int Clin Psychopharmacol 3:215-229.
24. McMillan DE (1973). Drugs and punished responding I: rate-dependent effects under multiple schedules. J Exp Anal Behav 19:133-145.
25. Mirza NR, Watjen F, Hartz BP, Teuber L, Nielsen EØ, Mathiasen LI, et al. (2003). NS2710: a novel anxiolytic with a dual mechanism of action. Behav Pharmacol 14(Suppl 1):S24.
26. Robbins TW (1975). The potentiation of conditioned reinforcement by psychomotor stimulant drugs: a test of Hill's hypothesis. Psychopharmacologia 45: 103-115.
27. Robbins TW (1981). Behavioural determinants of drug action: rate-dependency revisited. In: Cooper SJ, editor. Theory in psychopharmacology. Vol. 1. London: Academic Press, pp. 1-63.
28. Sallee FR, Sethuraman G, Sine L, Liu H (2000). Yohimbine challenge in children with anxiety disorders. Am J Psychiatry 157:1236-1242.
29. Sanger DJ (1988). Behavioural effects of the α2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine. Psychopharmacology 96:243-249.
30. Shannon M, Battaglia G, Glennon RA, Titeler M (1984). 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2- aminopropane (2,5-DMA). Eur J Pharmacol 102:23-29.
31. Spealman RD (1979). Comparison of the drug effects on responding punished by pressurized air or electric shock delivery in squirrel monkeys: pentoparbital, chlordiazepoxide, D-amphetamine and cocaine. J Pharmacol Exp Ther 209:309-315.
32. Wuttke W, Kelleher RT (1970). Effects of some benzodiazepines on punished and unpunished behavior in the pigeon. J Pharmacol Exp Ther 172: 397-405.